Your browser doesn't support javascript.
loading
International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism.
Tian, Mei; Zuo, Chuantao; Cahid Civelek, A; Carrio, Ignasi; Watanabe, Yasuyoshi; Kang, Keon Wook; Murakami, Koji; Prior, John O; Zhong, Yan; Dou, Xiaofeng; Yu, Congcong; Jin, Chentao; Zhou, Rui; Liu, Fengtao; Li, Xinyi; Lu, Jiaying; Zhang, Hong; Wang, Jian.
Affiliation
  • Tian M; Department of Nuclear Medicine and PET Center, Huashan Hospital, Fudan University, Shanghai, 200235, China. tianmei@fudan.edu.cn.
  • Zuo C; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China. tianmei@fudan.edu.cn.
  • Cahid Civelek A; Human Phenome Institute, Fudan University, Shanghai, 201203, China. tianmei@fudan.edu.cn.
  • Carrio I; Department of Nuclear Medicine and PET Center, Huashan Hospital, Fudan University, Shanghai, 200235, China. zuochuantao@fudan.edu.cn.
  • Watanabe Y; National Center for Neurological Disorders & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China. zuochuantao@fudan.edu.cn.
  • Kang KW; Department of Radiology and Radiological Science, Division of Nuclear Medicine and Molecular Imaging, Johns Hopkins Medicine, Baltimore, MD, 21287, USA. acivele1@jhmi.edu.
  • Murakami K; Research Institute and Department of Nuclear Medicine, Hospital Sant Pau, Autonomous University of Barcelona, 08025, Barcelona, Spain.
  • Prior JO; Laboratory for Pathophysiological and Health Science, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo, 650-0047, Japan.
  • Zhong Y; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, 03080, Korea.
  • Dou X; Department of Radiology, Juntendo University Hospital, Tokyo, 113-8431, Japan.
  • Yu C; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland.
  • Jin C; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China.
  • Zhou R; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China.
  • Liu F; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China.
  • Li X; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China.
  • Lu J; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China.
  • Zhang H; National Center for Neurological Disorders & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China.
  • Wang J; Department of Neurology, Huashan Hospital, Fudan University, Shanghai, 200235, China.
Eur J Nucl Med Mol Imaging ; 51(2): 434-442, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37789188
ABSTRACT

PURPOSE:

Presynaptic dopaminergic positron emission tomography (PET) imaging serves as an essential tool in diagnosing and differentiating patients with suspected parkinsonism, including idiopathic Parkinson's disease (PD) and other neurodegenerative and non-neurodegenerative diseases. The PET tracers most commonly used at the present time mainly target dopamine transporters (DAT), aromatic amino acid decarboxylase (AADC), and vesicular monoamine type 2 (VMAT2). However, established standards for the imaging procedure and interpretation of presynaptic dopaminergic PET imaging are still lacking. The goal of this international consensus is to help nuclear medicine practitioners procedurally perform presynaptic dopaminergic PET imaging.

METHOD:

A multidisciplinary task group formed by experts from various countries discussed and approved the consensus for presynaptic dopaminergic PET imaging in parkinsonism, focusing on standardized recommendations, procedures, interpretation, and reporting.

CONCLUSION:

This international consensus and practice guideline will help to promote the standardized use of presynaptic dopaminergic PET imaging in parkinsonism. It will become an international standard for this purpose in clinical practice.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Parkinsonian Disorders Type of study: Guideline Limits: Humans Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2024 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Parkinsonian Disorders Type of study: Guideline Limits: Humans Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2024 Document type: Article Affiliation country: